What ICD‑10‑CM diagnosis code is appropriate for billing a patient who presents with attention‑deficit symptoms while the ADHD work‑up is still pending?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Billable ICD-10-CM Code for Attention Deficits Pending ADHD Confirmation

Use ICD-10-CM code F90.8 ("Attention-deficit hyperactivity disorder, other type" or "Other specified ADHD") when billing for a patient presenting with attention-deficit symptoms while the full ADHD diagnostic work-up is still in progress. 1

Rationale for F90.8

  • The American Academy of Pediatrics explicitly recognizes F90.8 as the appropriate code for "other specified and unspecified ADHD" within the DSM-5 classification system used by primary care clinicians and third-party payers 1
  • This code allows you to document and bill for the clinical encounter while you are still gathering the required multi-setting information (parent reports, teacher rating scales, collateral history) needed to confirm one of the three primary ADHD presentations 1
  • F90.8 is billable when DSM-5 criteria are not yet fully met because you lack documentation of impairment in more than one major setting or have not yet ruled out alternative causes 1

When to Transition to a Definitive Code

Once your diagnostic work-up is complete and DSM-5 criteria are satisfied, transition to one of the three primary codes based on symptom pattern:

  • F90.0 (314.00): Predominantly Inattentive Presentation—when ≥6 inattention symptoms are present with <6 hyperactive-impulsive symptoms 1, 2
  • F90.1 (314.01): Predominantly Hyperactive-Impulsive Presentation—when ≥6 hyperactive-impulsive symptoms are present with <6 inattention symptoms 1, 2
  • F90.2 (314.01): Combined Presentation—when ≥6 symptoms are present in both domains 1, 2

Required Documentation to Support F90.8

To justify F90.8 billing while awaiting full confirmation, document the following in your clinical note:

  • Presenting symptoms that raise concern for ADHD (e.g., poor attention to detail, difficulty sustaining attention, organizational challenges, forgetfulness) 3
  • Pending collateral information from teachers, parents, or other observers using DSM-5-based rating scales such as Vanderbilt scales 2
  • Plan to verify symptom onset before age 12, duration ≥6 months, and impairment across ≥2 settings (home, school, work) 1, 3
  • Differential diagnoses being considered, such as anxiety, depression, learning disorders, or sleep disorders that can mimic ADHD 2, 4

Common Pitfalls to Avoid

  • Do not use F90.8 indefinitely—it is a temporary code while diagnostic work-up is in progress; prolonged use without completing the evaluation may trigger payer audits 1
  • Do not assign a definitive ADHD code (F90.0, F90.1, F90.2) prematurely before confirming DSM-5 criteria, as this requires documented impairment in multiple settings and ruling out alternative explanations 1
  • Avoid using unspecified symptom codes (e.g., R41.840 for "attention and concentration deficit") when ADHD is the suspected diagnosis, as F90.8 more accurately reflects your clinical suspicion and is better recognized by payers for ADHD-related services 1

Special Consideration for Preschool-Aged Children (4–6 Years)

  • For children younger than 4 years, there is insufficient evidence to recommend diagnosis or treatment other than parent training in behavior management, which does not require an ADHD diagnosis code 1
  • For ages 4–6 years, F90.8 can be used while gathering information through clinical interviews with parents, direct observation, and DSM-based rating scales with preschool normative data 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach for ADHD in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Inattentive ADHD Diagnosis and Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Evaluating and Managing ADHD in Perimenopausal Women – Evidence‑Based Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the symptoms and treatment options for Adult Attention Deficit Hyperactivity Disorder (ADHD)?
What is the next step in managing a patient with a moderately high score on the Attention Deficit Hyperactivity Disorder (ADHD) questionnaire and an average score on the Quiet Brain (QB) test?
What is the diagnostic evaluation and treatment approach for a patient suspected of having Attention Deficit Hyperactivity Disorder (ADHD)?
What is the recommended diagnostic and treatment approach for a 34-year-old woman suspected of having Attention Deficit Hyperactivity Disorder (ADHD)?
What is the recommended course of action for a patient with moderate to severe symptoms of inattention and borderline to mild symptoms of hyperactivity and impulsivity, as indicated by their BAARS-IV assessment scores, and who has been experiencing symptoms across multiple settings, including work and home, since adolescence?
What is the likely diagnosis and how should I treat multiple tinea corporis lesions on different body sites?
How should an adult (18‑65) with a high‑energy displaced coracoid process fracture (>5 mm displacement, involving the scapular neck or glenoid) be managed?
Can vancomycin cause lower extremity pain?
What is the significance of elevated GGT, mildly increased AST and ALT, macrocytosis, hypocalcemia, low bicarbonate with normal fasting glucose and renal function in a patient with chronic heavy alcohol use who is taking semaglutide, and what management steps are recommended?
After ten weeks on low‑dose amitriptyline 7.5 mg I still have gastrointestinal irritation and insomnia; should I continue the same dose indefinitely until symptoms resolve, and can I expect eventual full stabilization at this dose?
What is the recommended tapering schedule for discontinuing Lexapro (escitalopram) in an adult?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.